Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
29 052 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32019R0831

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

XXXXXXXX XXXXXX (XX) 2019/831

xx xxx 22. května 2019,

xxxxxx xx xxxx xxxxxxx II, XXX x X xxxxxxxx Evropského xxxxxxxxxx x Xxxx (ES) č. 1223/2009 x xxxxxxxxxxxx xxxxxxxxxxx

(Xxxx s xxxxxxxx pro XXX)

XXXXXXXX XXXXXX,

x xxxxxxx xx Smlouvu x xxxxxxxxx Xxxxxxxx unie,

x xxxxxxx xx nařízení Xxxxxxxxxx xxxxxxxxxx a Rady (ES) x. 1223/2009 xx xxx 30. xxxxxxxxx 2009 x xxxxxxxxxxxx xxxxxxxxxxx (1), x xxxxxxx xx xx. 15 xxxx. 1, xx. 15 xxxx. 2 xxxxxx pododstavec x xx. 31 xxxx. 1 xxxxxxxxx xxxxxxxx,

vzhledem x xxxxx důvodům:

(1)

Xxxxxxxx Evropského xxxxxxxxxx x Xxxx (ES) x. 1272/2008 (2) stanoví xxxxxxxxxxxxxx xxxxxxxxxxx xxxxx jako xxxxx xxxxxxxxxxxxxx, xxxxxxxxxxx xxxx toxických xxx xxxxxxxxxx (CMR) xx xxxxxxx vědeckého xxxxxxxxx Xxxxxx pro xxxxxxxxxx xxxxx Evropské agentury xxx xxxxxxxx xxxxx. Xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 A, látky XXX xxxxxxxxx 1X xxxx látky XXX xxxxxxxxx 2 x xxxxxxxxxx xx úrovni důkazů x xxxxxx vlastnostech CMR.

(2)

Xxxxxx 15 xxxxxxxx (ES) x. 1223/2009 xxxxxxxx xxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx látky xxxxxxxxxxxxx podle části 3 přílohy XX xxxxxxxx (ES) x. 1272/2008 (xxxxx XXX) jako xxxxx CMR xxxxxxxxx 1 X, xxxxxxxxx 1X xxxx kategorie 2. Xxxxx XXX však xxxx xxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, xxxxx xxxx xxxxxxx podmínky xxxxxxxxx x xx. 15 xxxx. 1 xxxxx xxxx xxxx x xx. 15 xxxx. 2 druhém xxxxxxxxxxx xxxxxxxx (ES) x. 1223/2009. Xxxxx nařízením xx xxxxxxx nařízení (XX) x. 1223/2009. Vykládat xxxxx Xxxx, xxxxxx xxxxxx 15 xxxxxxxx (XX) x. 1223/2009, xx oprávněn xxxxx Xxxxxx xxxx Xxxxxxxx unie.

(3)

X xxxxx jednotného xxxxxxxxx xxxxxx látek XXX v rámci xxxxxxxxx xxxx, xxxxxxxxx xxxxxx xxxxxxx xxxxxxx pro xxxxxxxxxxx xxxxxxxx a příslušné xxxxxxxxxxxx orgány, xxxxx x xxxxxxxxx xxxxxx úrovně xxxxxxx xxxxxxxx xxxxxx xx xxxxxxx xxxxx XXX xxxx xxx xxxxxxxx na xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení xxxx xxxxxxxxxx látek v přílohách XXX a V uvedeného xxxxxxxx. Xxxxx xxxx xxxxxxx xxxxxxxx xxxxxxxxx x xx. 15 xxxx. 1 druhé xxxx xxxx x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxx xxxxxxxx (XX) č. 1223/2009, seznamy xxxxx podléhajících omezení xxxx povolených látek x xxxxxxxxx III a V uvedeného xxxxxxxx by xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(4)

Xxxx nařízení xx xxxxxxxx na xxxxx, xxxxx byly podle xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxxx xxxx látky XXX xx xxx 1. xxxxxxxx 2018, xxx se xxxxx xxxxxxxxxxx nařízení Xxxxxx (XX) 2017/776 (3).

(5)

Xxxxx xxx x xxxxxx látky XXX, xxx něž xxxx předložena xxxxxx x xxxxxxxxx použití x xxxxxxxxxxxx xxxxxxxxxxx, nebylo xxxxxxxxx, xx xxxx xxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxx x xx. 15 odst. 1 druhé xxxx xxxx x xx. 15 xxxx. 2 xxxxxx pododstavci xxxxxxxx (XX) x. 1223/2009. Xx xx xxxx xxxxx Xxxxxxxxxx-15, Xxxxxxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxxx, sloučenin xxxxxxxx perborité a perboritanů xxxxxxx.

(6)

Xxxxx xxxxxxxxxx-3-xxxxxxxxxxxxxxxxx, xxxxx xxxxx xxxxx Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxxxxx (XXXX) xxx Quaternium-15, xx x xxxxxxxx xxxx xxxxxxx v položce 31 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 jako xxxxx xxxxxxxx v koncentraci xx 0,2 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxx-15 xx xxxx cis- x trans-isomerů, xxxxx xxx-xxxxxx xxx xxxxxxxxx Xxxxxx (XX) č. 790/2009 (4) xxxxxxxxxxxx xxxx xxxxx XXX kategorie 2. Xxxx klasifikace xx xxxxx použitelnou xxx 1. xxxxxxxx 2010. X xxxxxxx x xx. 15 xxxx. 1 xxxxxx větou xxxxxxxx (ES) x. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx jako xxxxxxxxx 2 xxxxxxx v kosmetických xxxxxxxxxxx, xxxx-xx xxxxxxxxxx Xxxxxxxx xxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxx (xxxx xxx „VVBS“) x xxxxxxxx xxxx xxxxxxxx xxx xxxxxxx x xxxxxxxxxxxx přípravcích. Xx xxxxx 13. x 14. xxxxxxxx 2011 xxxxx XXXX xxxxxxx xxxxxxxxxx xxxxxxxx xx látky Quaternium-15 (xxx-xxxxxx) (5), ve xxxxxx xxxxxx x xxxxxx, že xx xxxxxxx dostupných xxxxx xxxxx stanovit xxxxxxxxxx xxxxxxx xxxxx Xxxxxxxxxx-15 v kosmetických přípravcích. X xxxxxxx xx xxxxxxxxxxx xxx-xxxxxxx xxxxxxxxxx v látce Xxxxxxxxxx-15 jako xxxxx XXX kategorie 2 x xx xxxxxxxxxx XXXX xx měla xxx xxxxx Xxxxxxxxxx-15 xxxxxx xx xxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 a doplněna xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX uvedeného xxxxxxxx.

(7)

Xxxxx 2-xxxxxxxxxxxxx, jejíž xxxxx xxxxx XXXX xxx Chloroacetamide, xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 41 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx xx 0,3 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxxxxxxx byla xxxxx nařízení (XX) x. 1272/2008 xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2. Xxxx xxxxxxxxxxx xx xxxxx použitelnou xxxx 1. xxxxxxxxx 2010, xxx xx xxxxx, xxx xx xxx xxxxx stala xxxxxxxxxx xxxxxxxxxx hlav XX, XXX x XX xxxxxxxx (XX) č. 1272/2008. X xxxxxxx x xx. 15 xxxx. 1 druhou xxxxx nařízení (XX) x. 1223/2009 může být xxxxx xxxxxxxxxxxxx jako xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, byla-li xxxxxxxxxx XXXX x xxxxxxxx xxxx xxxxxxxx xxx xxxxxxx x xxxxxxxx přípravcích. Xxx 22. xxxxxx 2011 vydal XXXX xxxxxxx stanovisko xxxxxxxx xx xxxxx Xxxxxxxxxxxxxxx (6), ve xxxxxx xxxxxx x xxxxxx, xx xx základě dostupných xxxxx xxxx xxxx xxxxx při použití x xxxxxxxxxxx xx 0,3 % xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxxxxx bezpečná. X xxxxxxx na klasifikaci xxxxx Xxxxxxxxxxxxxxx xxxx xxxxx CMR kategorie 2 x xx xxxxxxxxxx XXXX xx měla xxx tato xxxxx xxxxxx xx xxxxxxx xxxxxxxxxxxxx xxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxx v příloze X xxxxxxxx (ES) x. 1223/2009 x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx II xxxxxxxxx xxxxxxxx.

(8)

Xxxxx xxxxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx v položce 7 xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009 xxxx xxxxx povolená x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxxx xx 35 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxxxxxxxxxx xxx xxxxx xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 2. Tato xxxxxxxxxxx xx stala xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010. X xxxxxxx x xx. 15 odst. 1 xxxxxx větou xxxxxxxx (XX) x. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx xxxx kategorie 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xxxx-xx xxxxxxxxxx VVBS x xxxxxxxx xxxx xxxxxxxx xxx použití x xxxxxxxx xxxxxxxxxxx. Xxx 11. prosince 2012 xxxxx XXXX vědecké xxxxxxxxxx xxxxxxxx xx xxxxx xxxxxxxxxxxxx (7). Dne 25. xxxxxx 2015 vydal XXXX xxxx stanovisko (8), xxxxx xxxx revidováno dne 28. xxxxx 2015. V tomto revidovaném xxxxxxxxxx dospěl XXXX x xxxxxx, xx xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxx xx 35 % v lacích xx xxxxx x xxxx použití xx sprejích xxxxxx xxxx xxxxxxxxxx xx xxxxxxxx xxx xxxxxxxxxxxx. X xxxxxxx xx xxxxxxxxxxx xxxxxxxxxxxxxx xxxx látky XXX xxxxxxxxx 2 x xx stanovisko XXXX x xxxxxxxx k tomu, xx xxxxxx známa a ve xxxxxxxxxx XXXX xxxxxxxxx xxxxx další xxxxxxx xxxxxxxxxxxxxx v kosmetických xxxxxxxxxxx, xx xxxx látka xxxx xxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení v příloze XXX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX uvedeného nařízení.

(9)

Xxxxx xxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 13 xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009 xxxx xxxxx povolená x xxxxxxxxxxx xxx xxxxxxx xxxxx x xxxxxxxxxxx xx 5 % v přípravku připraveném x xxxxxxx. X xxxxxxxx době xx xxxx xxxxxxx x xxxxxxx 5 xxxxxxx X xxxxxxxx (ES) č. 1223/2009 xxxx látka xxxxxxxx x xxxxxxxxxxx xxx ústní xxxxxxx x xxxxxxxxxxx xx 0,1 % a v jiných xxxxxxxxxxx x xxxxxxxxxxx xx 0,2 %. Xxxxxxxxxxx byl xxxxxxxxxxxx xxxx xxxxx CMR xxxxxxxxx 1X xxxxxxxxx Xxxxxx (XX) x. 605/2014 (9). Xxxx klasifikace xx xxxxx použitelnou dne 1. xxxxx 2016. X xxxxxxx x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxxx xxxxxxxx (XX) č. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx jako látky XXX kategorie 1 X xxxx 1B v kosmetických xxxxxxxxxxx výjimečně xxxxxxx, xxxxx xxxx poté, xx xxxx klasifikovány xxxx látky XXX, xxxxxxx xxxxxx xxxxxxxx xxxxxx xxxxxxxx, xx xxxxxx k dispozici xxxxx xxxxxx alternativní xxxxx, xx xxxx xxxxxx xxxxxx xx určité xxxxxxx kategorie přípravku xx známou expozicí x xx byla xxxx xxxxx XXXX xxxxxxxxxx x xxxxxxxx xxxx xxxxxxxx. Xxx 7. xxxxxxxxx 2014 dospěl XXXX xx xxxx xxxxxxxxxx (10) k závěru, xx „xxx tvrzení nebo xxxxxxxx nehtů xxxxx xxx xxxxxxxx použity xxxxxxxxx xxx xxxxxxx xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxx 2,2 % volného xxxxxxxxxxxx“. Xxxxxxx xxxx xxxxxx xxxxxxxxx, že xxxxxx x xxxxxxxxx xxxxx xxxxxx alternativní xxxxx xxx tvrzení nehtů, xxx by být xxxxxxxxxxx vyňat xx xxxxxxx xxxxx podléhajících xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009. Xxxxxxxx x xxxx, xx xxxxxx xxxxxx xxxxxx xx xxxx xxxxxxx xxxxxxxxxxxx, xxxx xx xxx tato xxxxx xxxxxx xx xxxxxxx xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze X xxxxxxxxx xxxxxxxx. Xxxxxxxxxxx xx xxx xxx xxxxxx xxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(10)

Xxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxx xxxxx xxxx xxxxx xxxxxxxxxx xxxxxxx vodíku, které xxxx x xxxxxxxx xxxx xxxxxxx v položce 12 xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009. Tyto xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1X xxxxxxxxx (XX) x. 790/2009. Xxxx xxxxxxxxxxx se xxxxx xxxxxxxxxxx xx xxx 1. xxxxxxxx 2010. Xx použití xxxxxx xxxxx x xxxxxxxxxx xxxxxxxxxxx x xxxxxxx vlasů xxxx xxxxxx xxxxxx x xxxxxxxxx xx. 15 odst. 2 xxxxxxx xxxxxxxxxxx xxxxxxxx (XX) č. 1223/2009. Xxx 22. xxxxxx 2010 xxxxxx XXXX xx xxxx stanovisku (11) x xxxxxx, xx „xxxxxx xxxxxxx platná pro xxxxx, které xxxxxxxx xxxxxxx xxxxxx, xx xx xxxx xxxxxxxxx xx perboritan xxxxx x xxxxxxxx xxxxxxxxxx a že xxxxxxx xxxxxxxxxxx xxxxxxx xxxx xxxxxx x xxxxxxxxxx xxxxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx nejvýše 3 % xx osobu xxxxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxxxxxxxx“. Xxxxxxx xxxx xxxxxx xxxxxxxxx, že xxxxxx x xxxxxxxxx žádné xxxxxx alternativní xxxxx xxx xxxxx oxidace xxxxx, xxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxx xx xxxx xxx xxxxxx xx seznamu xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009 x xxxxxxxx xx seznam xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx II uvedeného xxxxxxxx.

(11)

Xxxxx xxx o určité xxxxx, jež xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxx nařízení (XX) č. 1272/2008 a pro xxx xxxx xxxxxx xxxxxx x xxxxxxxxx čl. 15 xxxx. 1 druhé xxxx xxxxxxxx (XX) x. 1223/2009, xxxx xxxxxxxxx, xx xxxxxxxx xxxxxxxxx v uvedeném xxxxxxxxxx je xxxxxxx. Xx xx týká xxxxx Trimethylbenzoyl xxxxxxxxxxxxxxxxx xxxxx, Furfural x Xxxxxxxxxxxxxxx xxxxxxxxx.

(12)

Xxxxx difenyl(2,4,6-trimetylbenzoyl)fosfin xxxx, xxxxx název xxxxx XXXX zní Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx (XXX), xxxx x xxxxxxxx xxxx xx příloh nařízení (XX) x. 1223/2009 zařazena. Xxxx xxxxx xxxx xxxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 2 xxxxxxxxx Xxxxxx (EU) x. 618/2012 (12). Tato xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxx 1. xxxxxxxx 2013. Dne 27. xxxxxx 2014 xxxxx XXXX xxxxxxx xxxxxxxxxx (13), x xxxx xxxxxx k závěru, xx xxxxx XXX xx xxxxxxxx xxx xxxxxxx xxxx přípravek k modeláži xxxxx x xxxxxxxxxxx xx 5,0 %, avšak xx xxx x xxxxx xxxxx xxxxxxxxxxxxxxx kůži. Vzhledem x xxxxxxxxxxxxxxxx xxxxxxx XXX xx kůži a vysokému xxxxxx expozice v důsledku xxxxx s kůží při xxxxxxxx přípravku xx xxxxx samotnými xxxxxxxxxxxx xx xxxxxxxxx XXX xxxx xxx xxxxxxx xx profesionální xxxxxxxxx. X xxxxxxx xx tyto xxxxxxxxxxx xx xxxxx XXX měla xxx xxxxxxxx na xxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX nařízení (XX) x. 1223/2009 pro xxxxxxxxxxxxx použití v systémech xxxxxxx xxxxx v koncentraci xxxxxxx 5 %.

(13)

Xxxxx 2-xxxxxxxxxx, xxxxx xxxxx podle XXXX xxx Furfural, xx xxxxxxx xxxx xxxxx xxxx xxxxxxxxxx xxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x x xxxxxxxx době xxxx xxxxxxxx xx příloh xxxxxxxx (XX) x. 1223/2009. Xxxx xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 xxxxx xxxxxxxx (XX) x. 1272/2008. Xxxx klasifikace xx xxxxx použitelnou xxxx 1. prosincem 2010. Xxx 27. xxxxxx 2012 xxxxxx XXXX xx xxxx xxxxxxxxxx (14) x xxxxxx, xx xxxxxxx látky Furfural x xxxxxxxxxxx do 10 xxx (0,001 %) x xxxxxxxxx xxxxxxxxxxx x xxxxxxx, včetně xxxxxxxxx xxx ústní xxxxxxx, xxxxxxxxxxxxx riziko xxx xxxxxx spotřebitele. X xxxxxxx na klasifikaci xxxxx Xxxxxxxx xxxx xxxxx CMR xxxxxxxxx 2 x xx xxxxxxxxxx XXXX xx látka Xxxxxxxx v koncentraci xxxxxxx 0,001 % xxxx být xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxxxxx omezení x xxxxxxx XXX nařízení (XX) x. 1223/2009.

(14)

Xxxxx xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx (XXXX), xxxxx xxxxx xxxxx XXXX xxx Xxxxxxxxxxxxxxx xxxxxxxxx, xx x xxxxxxxx xxxx uvedena xx seznamu jako xxxxxxxxxxx xxxxxxx x xxxxxxx 28 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxxxxx xxxxxxx 0,3 %. Xxxx xxxxx xxxx xxxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 2 nařízením Xxxxxx (EU) x. 944/2013 (15). Xxxx klasifikace xx xxxxx xxxxxxxxxxx xxx 1. xxxxx 2015. Xxx 18. xxxxxx 2014 xxxxxx XXXX stanovisko (16), xx xxxxxx xxxxxx x xxxxxx, že xx xxxxxxx xxxxxxxxxx údajů xxxxx xxxxx PHMB xxxxxxxxx xx xxxxxxxxx xxx xxxxxxxxxxxx, pokud xx x xxxxxxxxxxx nejvýše 0,3 % použita xxxx xxxxxxxxxxx přísada x xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx. Xx xxxx xxxxxxxxxx xxxx XXXX xxxxxx dospěl x xxxxxx, xx xxxxxxxx xxxxxxx by xxxxx xxx xxxxxxxx xx xxxxx xxxxxxxxxxx xxxxxxx x/xxxx xxxxxxx, xxxxx xxx o kategorie kosmetických xxxxxxxxx, x xx xxxx xxxxxxxxx studie xxxxxxxx xxxxxxxx xxxxxxxx xx xxxxxxx reprezentativních kosmetických xxxxxxxxx. Dne 7. dubna 2017 xxxxxx XXXX nové xxxxxxxxxx (17), ve xxxxxx xxxxxx k závěru, že xx xxxxxxx xxxxxxxxxxxx xxxxx se xxxxxxx XXXX jako xxxxxxxxxxx xxxxxxx xx všech xxxxxxxxxxxx přípravcích x xxxxxxxxxxx xx 0,1 % považuje xx bezpečné, xxx xxxx xxxxxxx xx xxxxxxxx se xxxxxxxxxxxx. X xxxxxxx xx klasifikaci XXXX xxxx xxxxx XXX kategorie 2 x xx nové stanovisko XXXX by xxxxx XXXX xxxx xxx xxxxxxxx jako xxxxxxxxxxx xxxxxxx ve xxxxx xxxxxxxxxxxx přípravcích, x xxxxxxxx xxxxxxxx, xxx mohou xxxx x xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx při xxxxxxxxxx, x xxxxxxxxxxx xxxxxxx 0,1 %. Podmínky xxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xx proto xxxx být xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(15)

Xxxxx xxx x xxxxxx xxxxxxx látek, xxxxx byly klasifikovány xxxx xxxxx XXX xxxxx xxxxxxxx (ES) x. 1272/2008, žádná xxxxxx xx xxxxxxxxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx nebyla xxxxxxxxxx. Tyto látky xx xxxx xxx xxxxxxxx na xxxxxx xxxxxxxxxx látek v příloze XX xxxxxxxx (ES) x. 1223/2009 x xxxxxxxx vyňaty xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení nebo xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx. Xx xx xxxx xxxx xxxx xxxxxxxxx xxxxxxxxx xxxx, xxxxx xxxx x xxxxxxxx době xxxxxxx x xxxxxxxxx 1x x 1x přílohy III xxxxxxxx (XX) x. 1223/2009.

(16)

Xxxxxxx xxxxxxxxxx boru, které xxxx v současné xxxx xxxxxxx x xxxxxxxxx 1x x 1x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009, x xxxxxxxxxx-xxxxxxxxxxxxx xxxx xxxxxxxxx (XX) č. 790/2009 xxxxxxxxxxxxx xxxx xxxxx CMR xxxxxxxxx 1B. Tato xxxxxxxxxxx se stala xxxxxxxxxxx xx xxx 1. xxxxxxxx 2010. X xxxxxxx x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxx XXX kategorie 1 X xxxx 1B v kosmetických xxxxxxxxxxx výjimečně xxxxxxx, xxxxx xxxx xxxx, xx xxxx klasifikovány xxxx látky XXX, xxxxxxx určité xxxxxxxx. Xxx 22. června 2010 xxxxx XXXX xxxxxxxxxx (18), x xxxx xxxxxx k závěru, xx xxxxxxx xxxxxxxxxx boru, xxxxx xxxx v současné xxxx xxxxxxx x xxxxxxxxx 1x x 1x přílohy XXX xxxxxxxxx xxxxxxxx, xxxx xxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xx xxxxxxxx xxxxxxxx bezpečné. Xxxxxxx xxxxxx xxxxxx xxxxxx na xxxxxx xxxxxxx x xxxxxx xxxxxxxxx, xx xxxxxx k dispozici xxxxx xxxxxx xxxxxxxxxxxx xxxxx xxx xxxxx xxxxxxxxxxxx použití uvedených x xxxxxxx III nařízení (XX) x. 1223/2009, xxxx xx xxx xxxxxxx xxxxxxxxxx boru xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX uvedeného xxxxxxxx x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009. Xxxxx jde x xxxxxxxxxx-xxxxxxxxxxxxx, xxxxxx xxxxxx žádost xx xxxxxx xxxxxxx x XXXX xx xxxxxxxxx xxxx xxxxxxxxx. Xxxxxxx xxxxx by proto xxxx xxx xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(17)

Xxxxxxxxxx čl. 31 xxxx. 1 nařízení (XX) x. 1223/2009 xxxxxxx, xx xxxxxxxxxxx-xx xxxxxxx xxxxxxxx xxxxx v kosmetických xxxxxxxxxxx xxxxxxxxxxx riziko xxx xxxxxx xxxxxx, které xxxxxxxx xxxxx na xxxxxx Xxxxxxxxxxxx, xxxx Xxxxxx xx xxxxxxxxxx x XXXX xxxxxxxxxxxxx způsobem xxxxxx xxxxxxx XX xx XX xxxxxxxxx xxxxxxxx. Xxxxxx konzultovala XXXX xxxxxxx bezpečnosti xxxxxxxx xxxxx, xxxxx xxxx x xxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx xxxxxxxxxxxxxx xxxx látky CMR xxxxxxxxx 1 X, 1X xxxx 2. Xx xx xxxx xxxxxxxx xxxxxxxxx xxxx, xxxxx x xxxxx paraformaldehyd a methylenglykol.

(18)

Xxxxxxx xxxxxxxxxx xxxx, v současné xxxx uvedené x xxxxxxxxx 1x x 1x xxxxxxx XXX nařízení (XX) x. 1223/2009, jiné xxx xxxxxxxxxx uvedené x 16. xxxx xxxxxxxxxx, xxxxxx xxxxxxxxxxxxx xxxx látky XXX. Xxx 12. xxxxxxxx 2013 xxxxx VVBS stanovisko xxxxxxxx xx xxxxxxxx, xxxxxxxxxxxxx x xxxxxxxxxxxx (19), xx xxxxxx dospěl k závěru, xx xx uvedené xxxxx, stejně xxxx xxxxxxx xxxx xxxx xxxxxx xxxxxxxx xxxxxx, xxxx je MEA-borát, XXXX-xxxxxxx, xxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx-xxxxx a boritan zinečnatý, xxxxxxxxx ve xxxxxxx xxxxxxxxx xx xxxxxxxx xxxxxxx, a proto xx xx obecná xxxxxxx xxxxxx xxx kyselinu xxxxxxx xxxx xxxxxxxxx xx celou xxxxxxx xxxxxxxx, xxxxxxxxxxxxx x xxxxxxxxxxxx. Xxxxxxxx xxxxxx byla xxxxxxxxx (XX) x. 790/2009 xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1X. Xxxx xxxxxxxxxxx se xxxxx xxxxxxxxxxx ke xxx 1. prosince 2010. Celá xxxxxxx xxxxxxxx, xxxxxxxxxxxxx x xxxxxxxxxxxx, x xxxxxxxx xxxxx x xxxxxxx skupině, které xxxx klasifikovány xxxx xxxxx CMR, xxxxxx xxxx ostatní xxxx xxxx xxxxxx kyseliny xxxxxx xx měly xxx s ohledem xx xxxxxxxxxx XXXX xxxxxx xx xxxxxxx látek xxxxxxxxxxxxx omezení x xxxxxxx XXX nařízení (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích v příloze XX xxxxxxxxx xxxxxxxx.

(19)

Xxxxx xxxxxxxxxxxxxxx je x xxxxxxxx xxxx xxxxxxx xx xxxxxxx x xxxxxxx 5 xxxxxxx V nařízení (ES) x. 1223/2009, xxxxx xx xxxxxx od formaldehydu xxxxxx xxxxxxxxxxxxx jako xxxxx XXX. Látka xxxxxxxxxxxxxx není v současné xxxx xx xxxxxx xxxxxxxx (XX) x. 1223/2009 xxxxxxxx. Ve xxxxx 26. x 27. xxxxxx 2012 přijal XXXX xxxxxxxxxx xxxxxxxx xx xxxxxxxxxxxxxxx (20), ve xxxxxx stanovil, xx xxxxxxxxxxxxxx je xx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxx, xxx xxxx x xxxx xxxxxxx xx xxxxxxxxxxx xx xxxxxxx roztocích, x xx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxx, xxx xxxx x xxxx xxxxxxx xx xxxxxxxxxxx xxxxxxxx nebo xxxxxxx. X xxxxxxx xx stanovisko XXXX xxxxxxxx xxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxx xxxxxxxxxxx z použití xxxxxx xxxxx x xxxxxxxxxxxx xxxxxxxxxxx. Xxxxxxxxxxxxxxx by xxxxx měl xxx xxxxx xx xxxxxxx xxxxxxxxxxxxx xxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (ES) č. 1223/2009 x xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx xx xxxx xxx xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(20)

Xxxxxxxx (XX) č. 1223/2009 xx xxxxx xxxx xxx xxxxxxxxxxxxx způsobem xxxxxxx.

(21)

Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxx xxxx x xxxxxxx xx stanoviskem Xxxxxxx xxxxxx xxx xxxxxxxxxx xxxxxxxxx,

XXXXXXX TOTO XXXXXXXX:

Xxxxxx 1

Xxxxxxx II, XXX x X xxxxxxxx (XX) x. 1223/2009 xx mění x xxxxxxx x xxxxxxxx xxxxxx xxxxxxxx.

Xxxxxx 2

Xxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxxxxxx xxxx xx xxxxxxxxx x Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.

Xxxx xxxxxxxx xx xxxxxxx v celém xxxxxxx x xxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx xxxxxxx.

X Xxxxxxx xxx 22. xxxxxx 2019.

Za Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx XXXXXXX

(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;342, 22.12.2009, s. 59.

(2)  Nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 xx xxx 16. prosince 2008 x&xxxx;xxxxxxxxxxx, označování a balení xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx xxxxxxx 67/548/EHS x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx nařízení (XX) x.&xxxx;1907/2006 (Úř. věst. L 353, 31.12.2008, x.&xxxx;1).

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (EU) 2017/776 xx dne 4.&xxxx;xxxxxx&xxxx;2017, xxxxxx se xxx xxxxx přizpůsobení xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx a směsí (Xx.&xxxx;xxxx.&xxxx;X&xxxx;116, 5.5.2017, x.&xxxx;1).

(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (ES) x.&xxxx;790/2009 xx xxx 10.&xxxx;xxxxx&xxxx;2009, kterým se xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;235, 5.9.2009, x.&xxxx;1).

(5)&xxxx;&xxxx;XXXX/1344/10, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_077.pdf.

(6)&xxxx;&xxxx;XXXX/1360/10, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_053.xxx.

(7)&xxxx;&xxxx;XXXX/1408/11, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_118.pdf

(8)&xxxx;&xxxx;XXXX/1547/15, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_170.xxx

(9)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (EU) x.&xxxx;605/2014 xx xxx 5.&xxxx;xxxxxx&xxxx;2014, kterým xx xxx účely xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx xx nebezpečnosti a bezpečného xxxxxxxxx x&xxxx;xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx pokroku mění xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Úř. věst. L 167, 6.6.2014, x.&xxxx;36).

(10)  SCCS/1538/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_164.xxx

(11)&xxxx;&xxxx;XXXX/1345/10, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_031.xxx

(12)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) x.&xxxx;618/2012 xx xxx 10.&xxxx;xxxxxxxx&xxxx;2012, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxxx mění xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Úř. věst. L 179, 11.7.2012, x.&xxxx;3).

(13)&xxxx;&xxxx;XXXX/1528/14, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_149.xxx.

(14)  SCCS/1461/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_083.xxx

(15)&xxxx;&xxxx;Xxxxxxxx Komise (EU) x.&xxxx;944/2013 ze dne 2.&xxxx;xxxxx&xxxx;2013, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku mění xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;261, 3.10.2013, s. 5).

(16)  SCCS/1535/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_157.xxx

(17)&xxxx;&xxxx;XXXX/1581/16, https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_204.pdf

(18)&xxxx;&xxxx;XXXX/1249/09, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_027.pdf

(19)  SCCS/1523/13, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_146.xxx

(20)  SCCS/1483/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_097.xxx

XXXXXXX

1)&xxxx;&xxxx;&xxxx;

Xxxxxxx XX se xxxx xxxxx:

x)

xxxxxxxx xx xxxx položky, xxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx látky

Chemický xxxxx/XXX

Xxxxx CAS

Číslo XX

x

x

x

x

„1385

Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX)

51229-78-8

426-020-3

1386

Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX), xxxxxxxxxx-15

51229-78-8

426-020-3

1387

2-Xxxxxxxxxxxxx

79-07-2

201-174-2

1388

Xxxxxxxxxxxxxxxxxxxxxxxxxxx

556-67-2

209-136-7

1389

Xxxxxxxxxxxxx; xxxxxxxxxxxxxxx

75-09-2

200-838-9

1390

2,2′-((3,3′,5,5′-xxxxxxxxxxx-(1,1′-xxxxxxx)-4,4′-xxxx)-xxx(xxxxxxxxxxx))-xxxxxxxxx

85954-11-6

413-900-7

1391

Xxxxxxxxxxx; xxxxxxx

75-07-0

200-836-8

1392

1-Xxxxxxxxxxx-6,7-xxxxxxx-4-xxx-1,4-xxxxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx

93107-30-3

413-760-7

1393

X-xxxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxxx-2-xx

872-50-4

212-828-1

1394

Xxxxxxxxxxxx; oxid xxxxxx

1303-86-2

215-125-8

1395

Xxxxxxxx xxxxxx [1]

Xxxxxxxx xxxxxx [2]

10043-35-3 [1]

11113-50-1 [2]

233-139-2 [1]

234-343-4 [2]

1396

Boritany, tetraboritany, xxxxxxxxxxxx x xxxx x xxxxxx xxxxxxxx xxxxxx, xxxxxx:

Xxxxxxxxxxx xxxxxxx xxxxxxxxxxx [1]

12280-03-4 [1]

234-541-0 [1]

2-xxxxxxxxxxxx, xxxxxxxxx x xxxxxxxxx boritou [2]

10377-81-8 [2]

233-829-3 [2]

(2-hydroxypropyl)amoniumdihydrogenorthoboritan [3]

68003-13-4 [3]

268-109-8 [3]

Xxxxxxx xxxxxxxx, xxxxxxxx xxx kyseliny xxxxxx [4]

12712-38-8 [4]

603-184-6 [4]

Xxxxxxxxxxxxxxx-xxxxx [5]

-[5]

— [5]

Xxxxxxx xxxxxxxxx [6]

1332-07-6 [6]

215-566-6 [6]

Xxxxxxx xxxxx, xxxxxxxxxxxx xxxxxxx xxxxxxx; xxxxx xxx xxxxxxxx borité [7]

1330-43-4 [7]

215-540-4 [7]

Xxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxx [8]

12267-73-1 [8]

235-541-3 [8]

Xxxxx sůl xxxxxxxx orthoborité [9]

13840-56-7 [9]

237-560-2 [9]

Xxxxxxxxxxxx xxxxxxx xxxxxxxxxx; borax xxxxxxxxxx [10]

1303-96-4 [10]

215-540-4 [10]

Xxxxxxxxxxxx xxxxxxx xxxxxxxxxxx; xxxxx xxxxxxxxxxx [11]

12179-04-3 [11]

215-540-4 [11]

1397

Xxxxxxxxxx sodný [1]

xxxxxxxxxxxxxxxxx xxxxx; xxxxxxxxxxxxx sodný [2]

15120-21-5 [1]

239-172-9 [1]

7632-04-4 [2]

10332-33-9 [2]

10486-00-7[2]

231-556-4 [2]

1398

Xxxxxxxx xxxxxxxxx (X3XX2(X2)), xxxxxxxxx xxx, xxxxxxxxx [1]

13517-20-9 [1]

239-172-9 [1]

xxxxxxxx perboritá, xxxxx xxx, xxxxxxxxxxx [2]

37244-98-7 [2]

234-390-0 [2]

xxxxxxxx xxxxxxxxx (HBO(O2)), xxxxx xxx, xxxxxxxxxxx xxxxxxxxxxxxx xxxxx hexahydrát [3]

10486-00-7 [3]

231-556-4 [3]

1399

Kyselina xxxxxxxxx, xxxxx sůl [1]

11138-47-9 [1]

234-390-0 [1]

xxxxxxxx perboritá, xxxxx xxx, monohydrát [2]

12040-72-1 [2]

234-390-0 [2]

xxxxxxxx xxxxxxxxx (HBO(O2)), xxxxx xxx, monohydrát [3]

10332-33-9 [3]

231-556-4 [3]

1400

Xxxxxxxxxx-xxxxxxxxxxxxx

75113-37-0

401-040-5

1401

Xxxxxxxxxxxxxxxxxx nikelnatý

14708-14-6

238-753-4

1402

Mankozeb (XXX); xxxxxx-X,X′-xxxxxxxxxx(xxxxxxxxxxxxxx), xxxxxxxxx xxxxxxx xx xxxxxxxxxx xxxx

8018-01-7

616-995-5

1403

Xxxxx (XXX); mangan-N,N′-ethylenbis(dithiokarbamát) (xxxxxxxxx)

12427-38-2

235-654-8

1404

Xxxxxxxxxxx (XXX); xxxxx-X-[({[(2,2-xxxxxxxx-2,3-xxxxxxx-1-xxxxxxxxxx-7-xx)xxx]xxxxxxxx} xxxxxxxxxxx)xxxxxxxx]-X-xxxxxxxxx-β-xxxxxxxx

82560-54-1

617-356-3

1405

X-xxxxxxxx-X-xxxxxx karbonylthiokarbamát

103122-66-3

434-350-4

1406

Chlorprofam (XXX); xxxxxxxxx-3-xxxxxxxxxxxxxxx

101-21-3

202-925-7

1407

Xxxxx-X-(xxxxxxxxxxxxxx)xxxxxxxxxxxx

109202-58-6

432-750-3

1408

Xxxxxxxxxxxxxxx-xxxxxx

13465-08-2

236-691-2

1409

(4-Xxxxxxxxxxx)[3-(3-xxxxxx-4-xxxxxxxxxx)xxxxxx]xxxxxxxxxxxxx

105024-66-6

405-020-7

1410

Xxxxx (XXX); xxxxxxx-X-[xxxxx(xxxx)xxxxxx]xxxxxxxxxxxx

14816-18-3

238-887-3

1411

Xxxxxxxxxx xxxxxx (XXX); xxxxxxx-2-xxxxx-4-[xxxxxxx (xxxxxx)xxxxxxxx]xxxxxxxx

77182-82-2

278-636-5

1412

Xxxxxxx směs: xxxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; ethyl-methyl-{2-[N-(hydroxymethyl)karbamoyl]ethyl}fosfonát

—

435-960-3

1413

(4-Fenylbutyl)fosfinová xxxxxxxx

86552-32-1

420-450-5

1414

Xxxxxxx xxxx: 4,7-bis(merkaptomethyl)-3,6,9-trithia-1,11-undekandithiol; 4,8-bis(merkaptomethyl)-3,6,9-trithia-1,11-undekandithiol; 5,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx

170016-25-8

427-050-1

1415

Xxxxxxxxxxx xxxxxxxxxx-xxxxxxxxxxxxxx(X2Xx6X13)

12056-51-8

432-240-0

1416

Xxxxx xxxxxxxxxx

71-48-7

200-755-8

1417

Xxxxxxxx xxxxxxxxxx

10141-05-6

233-402-1

1418

Xxxxxxxxx xxxxxxxxxx

513-79-1

208-169-4

1419

Xxxxxxx xxxxxxxxx

7718-54-9

231-743-0

1420

Xxxxxxxx xxxxxxxxx [1]

13138-45-9 [1]

236-068-5 [1]

xxxxxxxx xxxxxxx, sůl xxxxx [2]

14216-75-2 [2]

238-076-4 [2]

1421

Xxxxxxx xxxxxxx (xxxx)

69012-50-6

273-749-6

1422

Xxxxx x xxxx x xxxxxxxxxxxxxx xxxxxxxx xxxx, xxxxxxx xxxx, s xxxxxxx xxxxxx nikelnatého

92129-57-2

295-859-3

1423

Bahna x xxxx x xxxxxxxxxxxxxx rafinace xxxx, xxxxxxx mědi

94551-87-8

305-433-1

1424

Chloristan xxxxxxxxx; xxxxxxxx xxxxxxxxx, xxxxxxxxx xxx

13637-71-3

237-124-1

1425

Xxxxx didraselno-nikelnatý [1]

13842-46-1 [1]

237-563-9 [1]

xxxxx xxxxxxxx-xxxxxxxxx [2]

15699-18-0 [2]

239-793-2 [2]

1426

Nikl-bis(sulfamidát); xxxx-xxxxxxxx

13770-89-3

237-396-1

1427

Xxxxxxxxxxxxxxxxxx nikelnatý

14708-14-6

238-753-4

1428

Nikl-diformiát [1]

3349-06-2 [1]

222-101-0 [1]

xxxxxxxx xxxxxxxx, xxx xxxxx [2]

15843-02-4 [2]

239-946-6 [2]

mravenčí xxxxxxxx, xxx xxxx x xxxxx [3]

68134-59-8 [3]

268-755-0 [3]

1429

Xxxx-xxxxxxxx [1]

373-02-4 [1]

206-761-7 [1]

xxxx-xxxxxx [2]

14998-37-9 [2]

239-086-1 [2]

1430

Xxxx(XX)-xxxxxxxxx

553-71-9

209-046-8

1431

Xxxx-xxx(4-xxxxxxxxxxxxxxxxxx)

3906-55-6

223-463-2

1432

Xxxx(XX)-xxxxxxx; xxxx(XX)-xxxxxxx

2223-95-2

218-744-1

1433

Xxxx-xxxxxxxx

16039-61-5

—

1434

Xxxx(XX)-xxxxxxxx

4995-91-9

225-656-7

1435

Xxxxxxx xxxxxxxxx [1]

10028-18-9 [1]

233-071-3 [1]

xxxxxx xxxxxxxxx [2]

13462-88-9 [2]

236-665-0 [2]

xxxxx xxxxxxxxx [3]

13462-90-3 [3]

236-666-6 [3]

fluorid draselno-nikelnatý [4]

11132-10-8 [4]

- [4]

1436

Hexafluorokřemičitan xxxxxxxxx

26043-11-8

247-430-7

1437

Xxxxxxx nikelnatý

15060-62-5

239-125-2

1438

Hydrogenfosforečnan xxxxxxxxx [1]

14332-34-4 [1]

238-278-2 [1]

bis(dihydrogenfosforečnan) xxxxxxxxx [2]

18718-11-1 [2]

242-522-3 [2]

xxxxxxxxxxxxxxxx xxxxxxxxx [3]

10381-36-9 [3]

233-844-5 [3]

difosforečnan xxxxxxxxxxx [4]

14448-18-1 [4]

238-426-6 [4]

bis(fosfornan) xxxxxxxxx [5]

14507-36-9 [5]

238-511-8 [5]

xxxxxxxxxxxx xxxxx [6]

36026-88-7 [6]

252-840-4 [6]

xxxxxxxx xxxxxxxxxx, xxx xxxxxxx x xxxxx [7]

17169-61-8 [7]

- [7]

xxxxxxxx xxxxxxxxxxxx, xxxxxxxxx xxx [8]

19372-20-4 [8]

— [8]

1439

Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx-xxxxxxxxx

74195-78-1

—

1440

Xxxxxx xxxxxxxxx

557-19-7

209-160-8

1441

Xxxxxxx xxxxxxxxx

14721-18-7

238-766-5

1442

Xxxxxxxxxx xxxxxxxxx [1]

21784-78-1 [1]

244-578-4 [1]

xxxxxxxxxxxxxxx dinikelnatý [2]

13775-54-7 [2]

237-411-1 [2]

xxxxxxxxxx xxxxxxxxx (3:4) [3]

31748-25-1 [3]

250-788-7 [3]

kyselina křemičitá, xxx xxxxx [4]

37321-15-6 [4]

253-461-7 [4]

xxxxxxxxxxx-xxxxxxxxxx [orthosilikato(4-)]trinikelnatá(3-)kyselina [5]

12519-85-6 [5]

235-688-3 [5]

1443

Xxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxx

14874-78-3

238-946-3

1444

Xxxxxxxxxxxxx trinikelnatý; xxxxxxxxxx xxxxxxxxx

13477-70-8

236-771-7

1445

Xxxx(XX)-xxxxxx [1]

547-67-1 [1]

208-933-7 [1]

xxxxxxxxx kyselina, sůl xxxxx [2]

20543-06-0 [2]

243-867-2 [2]

1446

Xxxxxxxx xxxxxxxxx

12142-88-0

235-260-6

1447

Xxxxxxxxxxx xxxxxxxx

12137-12-1

—

1448

Xxxxxxxxxxxx xxxxxxxxxxxx

74646-29-0

—

1449

Xxxx xxxxxxxx s xxxxxxx xxxxx x xxxxxxx; X.X. xxxxxxxxxx xxxx 25; X.X. 77332 [1]

68186-89-0 [1]

269-051-6 [1]

xxxxxx xxxxxxxxxx-xxxxxxxxx [2]

58591-45-0 [2]

261-346-8 [2]

oxid xxxxxxx x xxxxx [3]

12737-30-3 [3]

620-395-9 [3]

1450

Trioxid xxxxxxxxx-xxxxxxxx; xxxxxxxxx xxxxxxxxx

12035-38-0

234-824-9

1451

Xxxxxxxx xxxxxxxxx-xxxxxxxxxx

15780-33-3

239-876-6

1452

Xxxxxxxxxxxxxx xxxxxxxxx

13689-92-4

237-205-1

1453

Xxxxxxxxx xxxxxxxxx

15586-38-6

239-646-5

1454

Xxxxxxxxxxx xxxxxxxxx

10101-96-9

233-263-7

1455

Xxxxxxx xxxxxxxxx

1314-05-2

215-216-2

1456

Xxxxxxxx xxxxxxxxx, xxx xxxxx a niklu

68130-19-8

—

1457

Diarsenid xxxxx [1]

12068-61-0 [1]

235-103-1 [1]

xxxxxxx xxxxx [2]

27016-75-7 [2]

248-169-1 [2]

1458

Xxxxxx xxxxx xxxxxxxx x obsahem xxxxx, xxxxx a xxxxxx; C.I. pigmentová xxxx 157; X.X. 77900

68610-24-2

271-853-6

1459

Xxxxxxxxxx xxxxxxxxx [1]

67952-43-6 [1]

267-897-0 [1]

xxxxxxxxx nikelnatý [2]

14550-87-9 [2]

238-596-1 [2]

xxxxx-xxxxxxxx-xxxxxx, xxxxxxxxx xxx [3]

71720-48-4 [3]

275-897-7 [3]

1460

Xxxx(XX)-xxxxxxxxxxxxxx [1]

16083-14-0 [1]

240-235-8 [1]

xxxx(XX)-xxxxxxxxx [2]

3349-08-4 [2]

222-102-6 [2]

xxxx-xxx(xxxxxxxxxxxxxx) [3]

39819-65-3 [3]

254-642-3 [3]

xxxx(XX)-xxxxxxxx-xxxxxx [4]

18721-51-2 [4]

242-533-3 [4]

xxxxxxxxx kyselina, xxxxxxxxxxxxxxx xxx [5]

18283-82-4 [5]

242-161-1 [5]

xxxxxxxxx xxxxxxxx, xxx niklu [6]

22605-92-1 [6]

245-119-0 [6]

xxxx-[xxx(2-xxxxxxxxxxxxx)] [7]

4454-16-4 [7]

224-699-9 [7]

2-xxxxxxxxxxxxx xxxxxxxx, xxx xxxxx [8]

7580-31-6 [8]

231-480-1 [8]

dimethylhexanová xxxxxxxx, xxx xxxxx [9]

93983-68-7 [9]

301-323-2 [9]

nikl(II)-isooktanoát [10]

29317-63-3 [10]

249-555-2 [10]

xxxxxxxxxxx xxxxxxxx, xxx niklu [11]

27637-46-3 [11]

248-585-3 [11]

xxxx-xxxxxxxxxxxxx [12]

84852-37-9 [12]

284-349-6 [12]

xxxx(XX)-xxxxxxxxxxx [13]

93920-10-6 [13]

300-094-6 [13]

xxxx(XX)-xxxxxxxxxxx [14]

85508-43-6 [14]

287-468-1 [14]

nikl(II)-neodekanoát [15]

85508-44-7 [15]

287-469-7 [15]

neodekanová kyselina, xxx niklu [16]

51818-56-5 [16]

257-447-1 [16]

xxxx(XX)-xxxxxxxxxxxxx [17]

93920-09-3 [17]

300-093-0 [17]

bis(D-glukonato-O 1,O 2)xxxx [18]

71957-07-8 [18]

276-205-6 [18]

xxxx-xxx(3,5-xx-xxxx-xxxxx-4-xxxxxxxxxxxxxx (1:2) [19]

52625-25-9 [19]

258-051-1 [19]

nikl(II)-palmitát [20]

13654-40-5 [20]

237-138-8 [20]

(2-ethylhexanoato-O)(isononanoato-O)nikl [21]

85508-45-8 [21]

287-470-2 [21]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [22]

85508-46-9 [22]

287-471-8 [22]

(isooktanoato-O)(neodekanoato-O)nikl [23]

84852-35-7 [23]

284-347-5 [23]

(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [24]

84852-39-1 [24]

284-351-7 [24]

(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [25]

85135-77-9 [25]

285-698-7 [25]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [26]

85166-19-4 [26]

285-909-2 [26]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [27]

84852-36-8 [27]

284-348-0 [27]

(isononanoato-O)(neodekanoato-O)nikl [28]

85551-28-6 [28]

287-592-6 [28]

xxxxxx xxxxxxxx, X6-19 rozvětvené, xxxx xxxxx [29]

91697-41-5 [29]

294-302-1 [29]

xxxxxx xxxxxxxx, X8-18 x nenasycené X18, xxxx xxxxx [30]

84776-45-4 [30]

283-972-0 [30]

xxxxxxxx-2,7-xxxxxxxxxxx kyselina, xxxxxxxxx xxx [31]

72319-19-8 [31]

[31]

1461

Xxxxxxxxx xxxxxxxxx [1]

7757-95-1 [1]

231-827-7 [1]

xxxxxxx xxxxxxxxx-xxxxxxxxxxx [2]

15851-52-2 [2]

239-967-0 [2]

xxxxxxxxx xxxxxxxxx-xxxxxxxxx [3]

15852-21-8 [3]

239-974-9 [3]

xxxxxxxxxxx-xxxxxxxx-xxxx xxxxxxxxx a xxxxx [4]

68130-36-9 [4]

268-585-7 [4]

1462

Xxxxx xxxxx (XxX) [1]

12007-00-0 [1]

234-493-0 [1]

borid xxxxxxx [2]

12007-01-1 [2]

234-494-6 [2]

xxxxx xxxxxxxx [3]

12007-02-2 [3]

234-495-1 [3]

xxxxx xxxxx [4]

12619-90-8 [4]

235-723-2 [4]

xxxxxxx xxxxxxxxx [5]

12059-14-2 [5]

235-033-1 [5]

xxxxxxxxx xxxxx [6]

12201-89-7 [6]

235-379-3 [6]

xxxxxx diniklu [7]

12035-64-2 [7]

234-828-0 [7]

xxxxxx xxxxx x xxxx [8]

65229-23-4 [8]

[8]

1463

Xxxxxxxxx xxxxxxxxx-xxxxxxxxx [1]

12004-35-2 [1]

234-454-8 [1]

xxxxxxx xxxxxxxxx-xxxxxxxxxx [2]

12035-39-1 [2]

234-825-4 [2]

xxxx xxxxx x xxxxxx [3]

12653-76-8 [3]

235-752-0 [3]

xxxxxxxx nikelnato-divanadičný [4]

52502-12-2 [4]

257-970-5 [4]

xxxxxxxx xxxxxxxxxx-xxxxxxxxx-xxxxxxxxxxxxx [5]

68016-03-5 [5]

268-169-5 [5]

trioxid xxxxxxxxx-xxxxxxxxxxx [6]

70692-93-2 [6]

274-755-1 [6]

xxxxxxxxx nikelnato-molybdenový [7]

14177-55-0 [7]

238-034-5 [7]

tetraoxid xxxxxxxxx-xxxxxxxxxx [8]

14177-51-6 [8]

238-032-4 [8]

xxxxxx, xxxxxxx xxxxx [9]

68515-84-4 [9]

271-112-7 [9]

xxxxxx xxxxxxxx-xxxxxxxxx [10]

12031-65-1 [10]

620-400-4 [10]

xxxx xxxxxxxxx a xxxxx [11]

12673-58-4 [11]

— [11]

1464

Xxxxxx-xxxxxxx-xxxx-xxxx

—

442-750-5

1465

Xxxx xxxxxxxxxxx

1313-27-5

215-204-7

1466

Xxxxxxxxxxxxxxxxxxx (DBTC)

683-18-1

211-670-0

1467

4,4′-bis(N-karbamoyl-4-methylbenzensulfonamid) xxxxxxxxxxxxx

151882-81-4

418-770-5

1468

Xxxxxxxxxxxxxxx; (2-xxxxx)xxxxxxxx

98-00-0

202-626-1

1469

1,2-Xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx; 4-xxxxxxxxxxxxxxxxxxxxxxx

106-87-6

203-437-7

1470

6-Xxxxxxxxxxxxxxx-1-xx-xxxxxxxxxxxxxxx

27610-48-6

429-960-2

1471

2-(2-Xxxxxxxxxxxxxxx)xxxxxxx (XXXX)

111-41-1

203-867-5

1472

1,2-Xxxxxxxxxxxxx

629-14-1

211-076-1

1473

(2,3-Xxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

3033-77-0

221-221-0

1474

1-(2-Xxxxx-5-xxxxxxxxxx)-2,2,2-xxxxxxxxxxxxx-1,1-xxxx-xxxxxxxxxxxx

214353-17-0

433-580-2

1475

(X)-3-[1-[4-[2-(xxxxxxxxxxxxx)xxxxxx]xxxxx]-2-xxxxxxxx-1-xxxx]xxxxx

82413-20-5

428-010-4

1476

4,4′-[1,3-Xxxxxxxxxx(1-xxxxxxxxxxxxx)]xxxxxxx

13595-25-0

428-970-4

1477

2-Xxxxx-6-xxxxxxxxxx

2040-90-6

433-890-8

1478

5-Xxxx-xxxxx-2-xxxxxxxxxxxx-1-xxxxx

—

444-970-7

1479

2-Xxxxxxx-3-xxxxxxx-5-xxxxxxxxxxxxxx-3-xx-xxxxxxxx-2-xx-1-xx

94723-86-1

425-150-8

1480

Xxxxxxxxxx (ISO); 2-{(XX)-1-[(2XX)-2-(4-xxxxxxxxxxxx) xxxxxxxxxxxx]xxxxx}-3-xxxxxxx-5-(xxxxx-3-xx)xxxxxxxx-2-xx-1-xx

139001-49-3

604-105-8

1481

Xxxxxxxxxxxx (XXX); (RS)-(EZ)-2-{1-[(2E)-3-chlorallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyklohex-2-en-1-on

149979-41-9

604-715-4

1482

3,3-(Ethylendioxy)estra-5(10),9(11)-dien-17-on

5571-36-8

427-230-8

1483

Androsta-1,4,9(11)-trien-3,17-dion

15375-21-0

433-560-3

1484

Reakční xxxx: kalcium-alkylsalicyláty (xxxxxxxxxx xxxxxx X10-X14 a X18-X30); xxxxxxx-xxxxxxxxxxxxx (xxxxxxxxxx xxxxxx X10-X14 a X18-X30); kalcium-alkylbenzenthioláty (xxxxxxxxxx xxxxxx X10-X14 x X18-X30)

—

415-930-6

1485

Xxxxxxxx 1,2-xxxxxxxxxxxxxxxxxxx; xxxxxxx-(xxxxxx X6-X8)xxxxxx, xxxxxxxxxx, xxxxxx xx C7

71888-89-6

276-158-1

1486

Reakční směs: xxxxxxx 4,4′-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenolu] x xxxxxxxx 6-xxxxx-5,6-xxxxxxx-5-xxxxxxxxxxx-1-xxxxxxxxx (1:2); xxxxxxxx 4,4′-xxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] x xxxxxxxx 6-xxxxx-5,6-xxxxxxx-5-xxxxxxxxxxx-1-xxxxxxxxx (1:3)

—

427-140-9

1487

Xxxxxxxxx 1-xxxxxxx-2-(4-(4-xxxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx)-7-xxxxx-3-xxxxxxxxxxxxxxxx

150202-11-2

422-670-7

1488

Xxxxxxxx 3-xxxxxxxxxx-4-xx-17-β -xxxxxxxxxxx

302-97-6

414-990-0

1489

Xxxxxxxx (X)-2-xxxxxxxxxxx-2-[2-(xxxxxxxxxxx)xxxxxxx-4-xx]xxxxxx

64485-90-1

431-520-1

1490

Xxxxxxxxxx-xxxxxxxxxxxxxxxx

5064-31-3

225-768-6

1491

2-Xxxxxxxxxx-(2-xxxxxxxxxxxxx)

7425-14-1

231-057-1

1492

Xxxxxxxxxx-xxxxxx

84-69-5

201-553-2

1493

Xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx; heptadekafluoroktan-1-sulfonová xxxxxxxx [1]

1763-23-1 [1]

217-179-8 [1]

xxxxxx-xxxxxxxxxxxxxxxxxxxxx; xxxxxx-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxx [2]

2795-39-3 [2]

220-527-1 [2]

xxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]

70225-14-8 [3]

274-460-8 [3]

amonium-perfluoroktansulfonát; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [4]

29081-56-9 [4]

249-415-0 [4]

lithium-perfluoroktansulfonát; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [5]

29457-72-5 [5]

249-644-6 [5]

1494

Xxxxx-[1-(2,4-xxxxxxxxxxxx)5-(xxxxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-3-xxxxxxxxxx]

103112-35-2

401-290-5

1495

1-Xxxx-2-xxxxxxxxxxxxxxxxxxxxx

158894-67-8

422-900-6

1496

1-Xxxxxxxxxxxxxxx-xxxxxxxxxxxxx

99464-83-2

444-950-8

1497

6,6′-Xxx(xxxxx-5,5′,6,6′-xxxxxxxxxx-5,5′-xxxxx)[xxxxxxxxxxx(5-(6-xxxxx-5,6-xxxxxxx-5-xxx-1-xxxxxxxxxxxxxxxxx)-6-xxxxxx-2-xxxxxxx]xx(xxxxxxxx-1-xxxxxxxx)

—

441-550-5

1498

Xxxxxxxxxxx (XXX); α,α,α-xxxxxxxxx-2,6-xxxxxxx-X,X-xxxxxxxx-x-xxxxxxxx; 2,6-xxxxxxx-X,X-xxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx; X,X-xxxxxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx

1582-09-8

216-428-8

1499

4-Xxxxx-2-xxxxxxxxxxx

1671-49-4

430-550-0

1500

Xxxxxxxxxx-4-[(4-[1-xxxxxxx-7-(4-xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxx-2-xxxxxx]xxx-2,5-xxxxxxxxxxxxxx)xxx]xxxxxxx

221354-37-6

432-270-4

1501

Xxxxxxx xxxx: xxxxxxxxxx-6-xxxxx-3-({2,5-xxxxxxxx-4-[(3-xxxxxxxxxxxx)xxx]xxxxx}xxx)-4-xxxxxxxxxxxxxxx-2-xxxxxxxx; xxxxxxxxx-3-({4-[(7-xxxxx-1-xxxxxxx-3-xxxxx-2-xxxxxx)xxx]-2,5-xxxxxxxxxxxxx}xxx)xxxxxxx

163879-69-4

438-310-7

1502

X,X′-(xxxxxxx-4,4′-xxxx)xxxxxxxxxxx

613-35-4

210-338-2

1503

Xxxxxxxxxxxxxx

108-91-8

203-629-0

1504

Xxxxxxxxx

110-85-0

203-808-3

1505

Xxxxxxxxxxxx

7803-49-8

232-259-2

1506

Xxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxx-xxxxxxxxxxxx [1]

5470-11-1 [1]

226-798-2 [1]

xxx(xxxxxxxxxxxxxxx-xxxxxx); xxxxxxxxxxxx-xxxxxx (2:1) [2]

10039-54-0 [2]

233-118-8 [2]

1507

Methylfenylendiamin; xxxxxxxxxxxxx

—

—

1508

Xxxxxxxxxxx; 4-xxxxxx-X-xxxxx-6-(1-xxxxxxxx)-2-xxxxxxxxxxxxx

110235-47-7

600-951-7

1509

Xxxxxxxxxxxxxxx-xxxxxxxxxxxxxx; xxxxxxxxxxxx-xxxxxx (1:1) [1]

10046-00-1 [1]

233-154-4 [1]

xxxxxxxxxxxx-xxxxxx [2]

20845-01-6 [2]

244-077-0 [2]

hydroxylamin-dihydrogenfosfát [3]

19098-16-9 [3]

242-818-2 [3]

hydroxylamin-4-methylbenzen-1-sulfonát [4]

53933-48-5 [4]

258-872-5 [4]

1510

(3-Chlor-2-hydroxypropyl)trimethylamonium-chlorid

3327-22-8

222-048-3

1511

Bifenyl-3,3′,4,4′-tetramin; 3,3′-xxxxxxxxxxxxxxx

91-95-2

202-110-6

1512

Xxxxxxxxx-xxxxxxxxxxxx [1]

6094-40-2 [1]

228-042-7 [1]

xxxxxxxxx-xxxxxxxxxxxxxx [2]

142-64-3 [2]

205-551-2 [2]

xxxxxxxxx-xxxxxx [3]

1951-97-9 [3]

217-775-8 [3]

1513

3-(Xxxxxxxxx-1-xx)-xxxxx[x]xxxxxxxxxx-xxxxxxxxxxxx

87691-88-1

421-310-6

1514

(2-Xxxxxxxxxx)xxxxxxxx-xxxxxxxxxxxx

19398-06-2

421-460-2

1515

(2-Xxxxxxxxxx)(3-xxxxxxxxxxxxx)xxxxxxx-xxxxxxx

40722-80-3

429-740-6

1516

4-[(3-Xxxxxxxxxx)(xxxxxxxx-1-xx)xxxxxx]xxxxxx-1,2-xxxxxxxxxxxxxxxxxxxx

159939-85-2

425-030-5

1517

Xxxxx-X,X-xxxxxxxxxxxxxxxxxxx-xxxxxxx

3724-43-4

425-970-6

1518

7-Xxxxxxx-6-[3-(xxxxxxxx-4-xx)xxxxxxx]xxxxxxxxxx-4(3X)-xx;

199327-61-2

429-400-7

1519

Xxxxxxxx reakce xxx(2-xxxxxxxxxxxxx) xxxxx x xxxxxxxxxxxxx (1:4)

220444-73-5

432-440-8

1520

3-Xxxxx-4-[(3-xxxxxxxxxxx)xxx]xxxxxx

202197-26-0

445-590-4

1521

Xxxxxxxxxxxxxx; 3,8-Xxxxxxx-1-xxxxx-6-xxxxxxxxxxxxxxxxxxxx-xxxxxx

1239-45-8

214-984-6

1522

(2XX)-2-xxxxx-3,3-xxxxxxxxxxxxxxxxx

144177-62-8

447-860-7

1523

9-Xxxxxxxxxxxxx-3-xxxx; (9-Ethylkarbazol-3-yl)amin

132-32-1

205-057-7

1524

(6R-trans)-1-((7-amonio-2-karboxylato-8-oxo-5-thia-1-azabicyklo-[4.2.0]okt-2-en-3-yl)methyl)pyridinium-jodid

100988-63-4

423-260-0

1525

Forchlorfenuron (XXX); 1-(2-chlor-4-pyridyl)-3-fenylmočovina

68157-60-8

614-346-0

1526

1,3-Dimethyltetrahydropyrimidin-2(1H)-on; dimethylpropylenmočovina

7226-23-5

230-625-6

1527

Chinolin

91-22-5

202-051-6

1528

Ketokonazol; 1-[4-(4-{[(2XX,4XX)-2-(2,4-xxxxxxxxxxxx)-2-(xxxxxxxx-1-xxxxxxxx)-1,3-xxxxxxxx-4-xx]xxxxxxx} fenyl)piperazin-1-yl]ethan-1-on

65277-42-1

265-667-4

1529

Metkonazol (XXX); (1XX,5XX;1XX,5XX)-5-(4-xxxxxxxxxxx)-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx

125116-23-6

603-031-3

1530

Xxxxxx-1-xxxxxx-4-{3-[1-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-5-xxx-4,5-xxxxxxxxxxxxxx-4-xxxxxx]xxxx-1-xx-1-xx}-3-(xxxxxxxxxxxxxxxxx)xxxxxxx-5-xxxx

183196-57-8

418-260-2

1531

1,3,5-Xxxx(2,3-xxxxx-2-xxxxxxxxxxxx)-1,3,5-xxxxxxx-2,4,6(1X,3X,5X)-xxxxx

26157-73-3

435-010-8

1532

2,2-Xxx(xxxxxxxxxxxxx)xxxxx-1-xx-xxxx[3-(xxxxxxxx-1-xx)xxxxxxxxx]; (TAZ)

52234-82-9

257-765-0

1533

4,4′-Methylendifenyl xxxxxxxxxxx; xxxxxxxxxxxxx-4,4′-xxxxxxxxxxx [1]

101-68-8 [1]

202-966-0 [1]

2,2′-xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-2,2′-xxxxxxxxxxx [2]

2536-05-2 [2]

219-799-4 [2]

x-(x-xxxxxxxxxxxxxxxx)xxxxx xxxxxxxxx; xxxxxxxxxxxxx-2,4′-xxxxxxxxxxx [3]

5873-54-1 [3]

227-534-9 [3]

xxxxxxxxxxxxxxx-xxxxxxxxxxx [4]

26447-40-5 [4]

247-714-0 [4]

1534

Xxxxxxx xxxxx (XXX); xxxxx-(X)-2-xxxxx-3-[2-xxxxx-5-(xxxxxxxx-1-xx-1,2-xxxxxxxxxxxxx)xxxxx]xxxxxxx

142891-20-1

604-318-6

1535

X-[6,9-xxxxxxx-9-[[2-xxxxxxx-1-(xxxxxxxxxxxxx)xxxxxx]xxxxxx]-6-xxx-1X-xxxxx-2-xx]xxxxxxxx

84245-12-5

424-550-1

1536

Xxxxxxxxxxxxx (XXX); (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

604-712-8

1537

2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxx

27366-72-9

435-470-1

1538

Xxxxxxx směs: 2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx[X-(2,4-xxxxxxxxxxxxx)-3-xxxxxxxxxxxx]; X-(2,4-xxxxxxxxxxxxx)-X′-(2-xxxxxxxxxxx)-2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx(3-xxxxxxxxxxxx); 2-[[3,3′-xxxxxxx-4′-[[1[[(2,4-xxxxxxxxxxxxx)xxxxx]xxxxxxxx]-2-xxxxxxxxx]xxx][1,1′-xxxxxxx]-4-xx]xxx]-X-(2-xxxxxxxxxxxxx)-3-xxx-xxxxxxxxx

434-330-5

1539

Xxxx, xxxx, xxxxx x zemní xxxx a jejich xxxxxxxx xxxxxxxxxx xx xxxxxxx destilace a/nebo xxxxxx xxxxx zpracování, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxxxxx

85536-20-5

85536-19-2

90641-12-6

90989-38-1

91995-20-9

92062-36-7

91995-61-8

101316-63-6

93821-38-6

90641-02-4

101316-62-5

90641-03-5

65996-79-4

101794-90-5

90640-87-2

84650-03-3

65996-82-9

90641-01-3

65996-87-4

90640-99-6

68391-11-7

92062-33-4

91082-52-9

68937-63-3

92062-28-7

92062-27-6

91082-53-0

91995-31-2

91995-35-6

91995-66-3

122070-79-5

122070-80-8

65996-78-3

94114-52-0

94114-53-1

94114-54-2

94114-56-4

94114-57-5

90641-11-5

8006-61-9

8030-30-6

8032-32-4

64741-41-9

64741-42-0

64741-46-4

64742-89-8

68410-05-9

68514-15-8

68606-11-1

68783-12-0

68921-08-4

101631-20-3

64741-64-6

64741-65-7

64741-66-8

64741-70-4

64741-84-0

64741-92-0

68410-71-9

68425-35-4

68527-27-5

91995-53-8

92045-49-3

92045-55-1

92045-58-4

92045-64-2

101316-67-0

64741-54-4

64741-55-5

68476-46-0

68783-09-5

91995-50-5

92045-50-6

92045-59-5

92128-94-4

101794-97-2

101896-28-0

64741-63-5

64741-68-0

68475-79-6

68476-47-1

68478-15-9

68513-03-1

68513-63-3

68514-79-4

68919-37-9

68955-35-1

85116-58-1

91995-18-5

93571-75-6

93572-29-3

93572-35-1

93572-36-2

64741-74-8

64741-83-9

67891-79-6

67891-80-9

68425-29-6

68475-70-7

68603-00-9

68603-01-0

68603-03-2

68955-29-3

92045-65-3

64742-48-9

64742-49-0

64742-73-0

68410-96-8

68410-97-9

68410-98-0

68512-78-7

85116-60-5

85116-61-6

92045-51-7

92045-52-8

92045-57-3

92045-61-9

92062-15-2

93165-55-0

93763-33-8

93763-34-9

64741-47-5

64741-48-6

64741-69-1

64741-78-2

64741-87-3

64742-15-0

64742-22-9

64742-23-0

64742-66-1

64742-83-2

64742-95-6

68131-49-7

68477-34-9

68477-50-9

68477-53-2

68477-55-4

68477-61-2

68477-89-4

68478-12-6

68478-16-0

68513-02-0

68516-20-1

68527-21-9

68527-22-0

68527-23-1

68527-26-4

68603-08-7

68606-10-0

68783-66-4

68919-39-1

68921-09-5

85116-59-2

86290-81-5

90989-42-7

91995-38-9

91995-41-4

91995-68-5

92045-53-9

92045-60-8

92045-62-0

92045-63-1

92201-97-3

93165-19-6

94114-03-1

95009-23-7

97926-43-7

98219-46-6

98219-47-7

101316-56-7

101316-66-9

101316-76-1

101795-01-1

102110-14-5

68476-50-6

68476-55-1

90989-39-2

287-502-5

287-500-4

292-636-2

292-694-9

295-281-1

295-551-9

295-323-9

309-868-8

298-725-2

292-625-2

309-867-2

292-626-8

266-013-0

309-971-8

292-609-5

283-483-2

266-016-7

292-624-7

266-021-4

292-622-6

269-929-9

295-548-2

293-766-2

273-077-3

295-543-5

295-541-4

293-767-8

295-292-1

295-295-8

295-329-1

310-170-0

310-171-6

266-012-5

302-688-0

302-689-6

302-690-1

302-692-2

302-693-8

292-635-7

232-349-1

232-443-2

232-453-7

265-041-0

265-042-6

265-046-8

265-192-2

270-077-5

271-025-4

271-727-0

272-186-3

272-931-2

309-945-6

265-066-7

265-067-2

265-068-8

265-073-5

265-086-6

265-095-5

270-088-5

270-349-3

271-267-0

295-315-5

295-430-0

295-436-3

295-440-5

295-446-8

309-871-4

265-055-7

265-056-2

270-686-6

272-185-8

295-311-3

295-431-6

295-441-0

295-794-0

309-974-4

309-987-5

265-065-1

265-070-9

270-660-4

270-687-1

270-794-3

270-993-5

271-008-1

271-058-4

272-895-8

273-271-8

285-509-8

295-279-0

297-401-8

297-458-9

297-465-7

297-466-2

265-075-6

265-085-0

267-563-4

267-565-5

270-344-6

270-658-3

271-631-9

271-632-4

271-634-5

273-266-0

295-447-3

265-150-3

265-151-9

265-178-6

270-092-7

270-093-2

270-094-8

270-988-8

285-511-9

285-512-4

295-432-1

295-433-7

295-438-4

295-443-1

295-529-9

296-942-7

297-852-0

297-853-6

265-047-3

265-048-9

265-071-4

265-079-8

265-089-2

265-115-2

265-122-0

265-123-6

265-170-2

265-187-5

265-199-0

268-618-5

270-725-7

270-735-1

270-736-7

270-738-8

270-741-4

270-771-8

270-791-7

270-795-9

270-991-4

271-138-9

271-262-3

271-263-9

271-264-4

271-266-5

271-635-0

271-726-5

272-206-0

272-896-3

272-932-8

285-510-3

289-220-8

292-698-0

295-298-4

295-302-4

295-331-2

295-434-2

295-442-6

295-444-7

295-445-2

296-028-8

296-903-4

302-639-3

305-750-5

308-261-5

308-713-1

308-714-7

309-862-5

309-870-9

309-879-8

309-976-5

310-012-0

270-690-8

270-695-5

292-695-4

1540

Xxxx, xxxx, xxxxx x xxxxx xxxx x xxxxxx xxxxxxxx xxxxxxxxxx xx použití xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,005 % hmotnostních benzo[a]pyrenu

90640-85-0

92061-93-3

90640-84-9

61789-28-4

70321-79-8

122384-77-4

70321-80-1

292-606-9

295-506-3

292-605-3

263-047-8

274-565-9

310-189-4

274-566-4

1541

Ropa, xxxx, dehet x xxxxx plyn x xxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxx destilace x/xxxx xxxxxx xxxxx xxxxxxxxxx, pokud xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx ≥ 0,005 % hmotnostních xxxxx[x]xxxxxx

85029-51-2

84650-04-4

84989-09-3

91995-49-2

121620-47-1

121620-48-2

90640-90-7

90641-04-6

101896-27-9

101794-91-6

91995-48-1

90641-05-7

84989-12-8

121620-46-0

90640-81-6

90640-82-7

92061-92-2

91995-15-2

91995-16-3

91995-17-4

101316-87-4

122384-78-5

84988-93-2

90640-88-3

65996-83-0

90640-89-4

90641-06-8

65996-85-2

101316-86-3

92062-22-1

96690-55-0

84989-04-8

84989-05-9

84989-06-0

84989-03-7

84989-07-1

68477-23-6

68555-24-8

91079-47-9

92062-26-5

94114-29-1

90641-00-2

68513-87-1

70321-67-4

92062-29-8

100801-63-6

100801-65-8

100801-66-9

73665-18-6

68815-21-4

65996-86-3

65996-84-1

285-076-5

283-484-8

284-898-1

295-310-8

310-166-9

310-167-4

292-612-1

292-627-3

309-985-4

309-972-3

295-309-2

292-628-9

284-901-6

310-165-3

292-603-2

292-604-8

295-505-8

295-275-9

295-276-4

295-278-5

309-889-2

310-191-5

284-881-9

292-610-0

266-017-2

292-611-6

292-629-4

266-019-3

309-888-7

295-536-7

306-251-5

284-892-9

284-893-4

284-895-5

284-891-3

284-896-0

270-713-1

271-418-0

293-435-2

295-540-9

302-662-9

292-623-1

271-020-7

274-560-1

295-544-0

309-745-9

309-748-5

309-749-0

277-567-8

272-361-4

266-020-9

266-018-8

1542

Xxxx, xxxx, xxxxx x xxxxx xxxx x jejich deriváty xxxxxxxxxx xx použití xxxxxxxxx a/nebo xxxxxx xxxxx xxxxxxxxxx, pokud xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxx-1,3-xxxxx

68607-11-4

68783-06-2

68814-67-5

68814-90-4

68911-58-0

68911-59-1

68919-01-7

68919-02-8

68919-03-9

68919-04-0

68919-07-3

68919-08-4

68919-11-9

68919-12-0

68952-79-4

68952-80-7

68955-33-9

68989-88-8

92045-15-3

92045-16-4

92045-17-5

92045-18-6

92045-19-7

92045-20-0

68131-75-9

68307-98-2

68307-99-3

68308-00-9

68308-01-0

68308-10-1

68308-03-2

68308-04-3

68308-05-4

68308-06-5

68308-07-6

68308-09-8

68308-11-2

68308-12-3

68409-99-4

68475-57-0

68475-58-1

68475-59-2

68475-60-5

68476-26-6

68476-29-9

68476-40-4

68476-42-6

68476-49-3

68476-85-7

68476-86-8

68477-33-8

68477-35-0

68477-69-0

68477-70-3

68477-71-4

68477-72-5

68308-08-7

271-750-6

272-182-1

272-338-9

272-343-6

272-775-5

272-776-0

272-873-8

272-874-3

272-875-9

272-876-4

272-880-6

272-881-1

272-884-8

272-885-3

273-173-5

273-174-0

273-269-7

273-563-5

295-397-2

295-398-8

295-399-3

295-400-7

295-401-2

295-402-8

268-629-5

269-617-2

269-618-8

269-619-3

269-620-9

269-630-3

269-623-5

269-624-0

269-625-6

269-626-1

269-627-7

269-629-8

269-631-9

269-632-4

270-071-2

270-651-5

270-652-0

270-653-6

270-654-1

270-667-2

270-670-9

270-681-9

270-682-4

270-689-2

270-704-2

270-705-8

270-724-1

270-726-2

270-750-3

270-751-9

270-752-4

270-754-5

269-628-2

1543

Xxxx[2-xxxxx-1-(xxxxxxxxxxx)xxxxx]xxxxxx

13674-87-8

237-159-2

1544

Xxxxxx xxxxx

22398-80-7

244-959-5

1545

Xxxxxxxx-xxxxxx

25155-23-1

246-677-8

1546

Xxxxxxxxxxxxxxxxxxxx [1]

25637-99-4 [1]

247-148-4 [1]

1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxx [2]

3194-55-6 [2]

221-695-9 [2]

1547

Xxxxxxxxxxxxxxx

109-99-9

203-726-8

1548

Xxxxxxxxx (xxxx avermektinu X1x x xxxxxxxxxxx X1x) (ISO) [1]

71751-41-2 [1]

615-339-5 [1]

avermektin X1x [2]

65195-55-3 [2]

265-610-3 [2]

1549

4-Xxxx-xxxxxxxxxxxxx xxxxxxxx

98-73-7

202-696-3

1550

Xxxxxxxxxxxxxxxx xxxxx; N,N,N′,N′-tetramethyl-4,4′-benzylidendianilin

129-73-7

204-961-9

1551

Fuberidazol (XXX); 2-(2-xxxxx)xxxxxxxxxxxx

3878-19-1

223-404-0

1552

Xxxxxxxxxxx (ISO); 2-xxxxx-X-(2,6-xxxxxxxxxxxxx)-X-(xxxxxxx-1-xxxxxxxx)xxxxxxxx

67129-08-2

266-583-0

1553

Xx-xxxx-xxxxxxxxxxxx

110-05-4

203-733-6

1554

Xxxxxxxxxxxxxxxxxxxxx

993-16-8

213-608-8

1555

2-Xxxxxxxxxx-10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx

57583-34-3

260-828-5

1556

2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)

15571-58-1

239-622-4

1557

Xxxxxxxxxx (XXX); 2-[2-xxxxx-4-(xxxxxxxxxxxxxx)xxxxxxx]xxxxxxxxxx-1,3-xxxx

99105-77-8

619-394-6

1558

Xxxxxxxxxx (XXX); (2-xxxxxxxxxxxxx-3-xx)xxxxxx-xxx-(1X,3X)-3-[(1X)-2-xxxxx-3,3,3-xxxxxxxxxxxx-1-xx-1-xx]-2,2-xxxxxxxxxxxxxxxxxxx-xxxxxxxxxx

82657-04-3

617-373-6

1559

Xxxxxxx-xxxxxx

84-75-3

201-559-5

1560

Xxxxxxx-xxxxxxxxxxxxxxxxxxxxxx

3825-26-1

223-320-4

1561

Xxxxxxxxxxxxxxxx kyselina

335-67-1

206-397-9

1562

N-ethyl-2-pyrrolidon; 1-xxxxxxxxxxxxxxx-2-xx

2687-91-4

220-250-6

1563

Xxxxxxxxxxx (XXX); 6-xxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xx

189278-12-4

606-168-7

1564

Xxxxxxx xxxxx

1303-00-0

215-114-8

1565

Xxxxx-xxxxxx

108-05-4

203-545-4

1566

Xxxxxxxxx (ISO); 2-chlor-3-fenoxy-6-nitroanilin

74070-46-5

277-704-1

1567

2-Ethylhexyl-(10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradekanoát)

57583-35-4

260-829-0

1568

Dimethylstannan-dichlorid

753-73-1

212-039-2

1569

4-Vinylcyklohexen

100-40-3

202-848-9

1570

Tralkoxydim (XXX); 2-(X-xxxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-xxxxxxxxxxxxxxx-2-xx-1-xx

87820-88-0

618-075-9

1571

Xxxxxxxxxx (XXX); 2-(X-xxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-(xxxxxxxxxx-2X-xxxxxxxxx-3-xx)xxxxxxxx-2-xx-1-xx

101205-02-1

405-230-9

1572

Xxxxxxxxx (ISO); 3-chlor-N-[3-chlor-2,6-dinitro-4-(trifluormethyl)fenyl]-5-(trifluormethyl)pyridin-2-amin

79622-59-6

616-712-5

1573

Penkonazol (XXX); 1-[2-(2,4-dichlorfenyl)pentyl]-1H-1,2,4-triazol

66246-88-6

266-275-6

1574

Fenoxykarb (ISO); xxxxx-X-[2-(4-xxxxxxxxxxxx)xxxxx]xxxxxxxx

72490-01-8

276-696-7

1575

Xxxxxx

100-42-5

202-851-5

1576

2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxx

97-99-4

202-625-6

1577

Xxxxxxxxxxx

50-00-0

200-001-8

1578

Xxxxxxxxxxxxxxx

30525-89-4

608-494-5

1579

Xxxxxxxxxx, xxxxxxxxxxxxxx

463-57-0

207-339-5

1580

Xxxxxxxxx (XXX); 1-xxxxx-3-[2-xxxx-2-(xxxxxxxxxxxx)xxxxxx]xxxxxxxx

57966-95-7

261-043-0

1581

Xxxxxxxxxxxxxxx, xxxxxxxxxx

—

—

1582

Xxxxxxxxxx (XXX); 2-{2-xxxxx-4-(xxxxxxxxxxxxxx)-3-[(2,2,2-xxxxxxxxxxxxxx)xxxxxx]xxxxxxx}xxxxxxxxxx-1,3-xxxx

335104-84-2

608-879-8

1583

1,2-Xxxxxxxxxxxxxxxxxxx kyselina, xxxxxxxxxxxx, xxxxxxxxxx x xxxxxxxx

68515-50-4

271-093-5

1584

Xxxxxxxxxxxxx (ISO); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx

203313-25-1

606-523-6

1585

Xxxxxxxx-xxxxxx; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx

31717-87-0

250-778-2

1586

Xxxxxxxxxxxxxx-xxxxxx; methyl-2-([4-(dimethylamino)-6-(2,2,2-trifluorethoxy)-1,3,5-triazin-2-yl]karbamoylsulfamoyl)-3-methylbenzoát

126535-15-7

603-146-9

1587

Imazalil (XXX); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx

35554-44-0

252-615-0

1588

Xxxxxxxx (XXX); 4-cyklohexyl-2,6-dimethylmorfolin

1593-77-7

216-474-9

1589

Imidazol

288-32-4

206-019-2

1590

Lenacil (XXX); 3-xxxxxxxxxx-6,7-xxxxxxx-1X-xxxxxxxxxx[x]xxxxxxxxx-2,4(3X,5X)-xxxx

2164-08-1

218-499-0

1591

Xxxxxxxxx (XXX); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx

139528-85-1

604-145-6

1592

2-Xxxxxx-1-(4-xxxxxxxxxxxxxxx)-2-xxxxxxxxxxxxxxx 1-on

71868-10-5

400-600-6

1593

2,3-Epoxypropyl-methakrylát

106-91-2

203-441-9

1594

Spiroxamin (XXX) 8-xxxx-xxxxx-1,4-xxxxxxxxxx[4.5]xxxxx-2-xxxxxxxx(xxxxx)(xxxxxx)xxxx

118134-30-8

601-505-4

1595

Xxxxxxxx; karbonitril

420-04-2

206-992-3

1596

Cyprokonazol (XXX); (2XX,3XX;2XX,3XX)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx

94361-06-5

619-020-1

1597

Xxxxxxxx-xxxxxxxxx xxxxxx

130328-20-0

603-404-0

1598

Xxxxxxxxx kademnatý

513-78-0

208-168-9

1599

Hydroxid xxxxxxxxx

21041-95-2

244-168-5

1600

Xxxxxxxx xxxxxxxxx

10325-94-7

233-710-6

1601

Xxxxxxxxxx-xxxxxxxx xxxxxxx[xxx(xxxxxxxxxxxxx)]xxxxxxx

77-58-7

201-039-8

1602

Xxxxxxxxx; 2-xxxxxx-4-xxxxxxxxxx

120-32-1

204-385-8

1603

Xxxxxxxxxxxx

84-65-1

201-549-0

1604

Xxxxxxxxxxxxxxxxxxxxx kyselina [1]

335-76-2 [1]

206-400-3[1]

xxxxxxx-xxxxxxxxxxxxxxxxxxxxx [2]

3108-42-7 [2]

221-470-5 [2] [3]

xxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]

3830-45-3 [3]

1605

X,X′-xxxxxxxxxxxxxxxxxx; X,X′-xxxxxxxxxxxxxxxxxxx; [xxxxxxxxxxx xxxxxxxx x X,X′-xxxxxxxxxxxxxxxxxxxxx]; [XXX]

xxxxx xxxxxxxxx teoretická xxxxxxxxxxx xxxxxxxxxxxxx formaldehydu xxx xxxxxx xx xxxxx je xx xxxxx, xxx je xxxxxxx na xxx, ≥ 0,1 % xxxxxxxxxxxx

5625-90-1

227-062-3

1606

Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-xxxxxxxxxxxxxxxxxxx (3:2);

[xxxxxxxxxxx xxxxxxxx x 3,3′-xxxxxxxxxxx [5–xxxxxxxxxxxxxxxxx]; [xxxxxxxxxxx uvolněný x xxxxxxxxxxx]; [XXX], xxxxx maximální teoretická xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx ohledu xx xxxxx xx xx xxxxx, xxx xx xxxxxxx xx trh, ≥ 0,1 % xxxxxxxxxxxx

—

—

1607

Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-hydroxypropylaminem (1:1);

[formaldehyd xxxxxxxx z α,α,α-xxxxxxxxx-1,3,5-xxxxxxx-1,3,5 (2X,4X,6X)-xxxxxxxxxxx]; [XXX], xxxxx xxxxxxxxx xxxxxxxxxx koncentrace xxxxxxxxxxxxx formaldehydu xxx xxxxxx na xxxxx xx xx xxxxx, xxx xx xxxxxxx xx xxx, ≥ 0,1 % xxxxxxxxxxxx

—

—

1608

Xxxxxxxxxxxxxx

60-34-4

200-471-4

1609

Xxxxxxxxxxx (XXX); (1RS,2RS;1RS,2RS)-1-(4-chlorfenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol); α-terc-butyl-β-(4-chlorofenoxy)-1H-1,2,4-triazol-1-ethanol

55219-65-3

259-537-6

1610

Thiakloprid (XXX); (Z)-3-(6-chlor-3-pyridylmethyl)-1-3-thiazolidin-2-ylidenkyanamid; {(2Z)-3-[(6-chlorpyridin-3-yl)methyl]-1,3-thiazolidin-2-yliden}kyanamid

111988-49-9

601-147-9

1611

Karbetamid (XXX); (X)-1-(xxxxxxxxxxxxxx)xxxxxxxxxxxxxxx (2R)-1-(ethylamino)-1-oxopropan-2-yl-fenylkarbamát

16118-49-3

240-286-6“

b)

položka 395 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx číslo

Identifikace xxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx CAS

Číslo ES

„395

Chinolin-8-ol x jeho xxxxxx

148-24-2

134-31-6

205-711-1

205-137-1“

2)&xxxx;&xxxx;&xxxx;

Xxxxxxx XXX xx xxxx xxxxx:

x)

xxxxxxx 1x, 1x, 7, 13 x&xxxx;51 xx zrušují;

b)

položka 12 xx xxxxxxxxx tímto:

Referenční xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxx

Xxxxx podmínek xxxxxxx x upozornění

Chemický xxxxx/XXX

Xxxxx x seznamu xxxxxx podle xxxxxxxx xxxxxxxxxxxx

Xxxxx XXX

Xxxxx XX

Xxxx xxxxxxx, xxxxx xxxx

Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxx x použití

Jiné

a

b

c

d

e

f

g

h

i

„12

Peroxid xxxxxx x xxxxxxx xxxxxxxxxx xxxx xxxxx, xxxxx peroxid xxxxxx xxxxxxxx, xxxxxx xxxxx xxxxxxxx xxxxxxx x xxxxxxx xxxxxxxxx, x xxxxxxxx těchto látek x xxxxxxx XX:

—

x. 1397, 1398, 1399

Hydrogen xxxxxxxx

7722-84-1

231-765-0

x)

Xxxxxxxxx na xxxxx

x)

12 % H2O2 (40 xxxxxx), xxxxxxxxxx xxxx xxxxxxxxxx

x) x) Xxxxxxxxxx xxxxxx xxxxxxxx.

x) x) x) x)

Xxxxxxxx xxxxxxx xxxxxx.

Xxxxxxxx xxxxx s xxxxx.

Xxx xxxxxxxx xxx xxxxxxxx vypláchněte vodou.

b)

Přípravky xx xxxx

x)

4 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)

Xxxxxxxxx xxx xxxxxxx xxxxx

x)

2 % X2X2, xxxxxxxxxx nebo xxxxxxxxxx

x)

Xxxxxxxxx xxx xxxxx xxxxxxx, xxxxxx xxxxx xxxx, xxxxx pasty x xxxxxxxxx xx xxxxxx xxxx xxxxxxxxxx xxxx

x)

≤ 0,1 % H2O2, xxxxxxxxxx nebo xxxxxxxxxx

x)

Xxxxxxxxx xx xxxxxx nebo xxxxxxxxxx xxxx

x)

&xx; 0,1 % ≤ 6 % H2O2, xxxxxxxxxx xxxx xxxxxxxxxx

x)

X prodeji xxxxx xxxxxx lékařům. X xxxxxxx cyklu xxxxxxx xxxx být xxxxx xxxxxxx xxxxxxxxx xxxxxx xxxxxxx xx xxxxxx xxxxxxxx Evropského xxxxxxxxxx x Xxxx 2005/36/XX&xxxx;(*1) xxxx pod xxxx xxxxxx xxxxxxxx, xxxxx je zaručena xxxxxxxxxx xxxxxx xxxxxxxxxxx.

Xxxx xxxxxx xxxxxxxxxxxx k xxxxxxxxx cyklu xxxxxxx.

Xxxxxxxxxx x xxxx xxxxxxxx 18 xxx.

x)

Xxxxxxxxxxx H2O2 xxxxxxxxxx xxxx xxxxxxxxxx xxxxxxx x procentech.

Nepoužívat x xxxx xxxxxxxx 18 xxx.

X prodeji xxxxx xxxxxx lékařům. X xxxxxxx xxxxx xxxxxxx xxxx být xxxxx xxxxxxx xxxxxxxxx xxxxx zubním xxxxxxx xxxx pod xxxx xxxxxx xxxxxxxx, pokud xx zaručena xxxxxxxxxx xxxxxx xxxxxxxxxxx.

Xxxx předat xxxxxxxxxxxx x xxxxxxxxx xxxxx xxxxxxx.

x)

Xxxxxxxxx xxxxxx xxx xxxx

x)

2 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)

Xxx xxx xxxxxxxxxxxxx xxxxxxx.

x)

Xx etiketě se xxxxx:

„Xxx pro profesionální xxxxxxx.

Xxxxxxxx xxxxx x xxxxx.

Xxx xxxxxxxx očí xxxxxxxx xxxxxxxxxxx xxxxx.

Xxxxxxxx xxxxxxx xxxxxx.“

x)

xxxxxxxx se xxxx položky, xxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxx

Xxxxx xxxxxxxx xxxxxxx x xxxxxxxxxx

Xxxxxxxx název/

INN

Název x xxxxxxx xxxxxx xxxxx xxxxxxxx nomenklatury

Číslo XXX

Xxxxx XX

Xxxx xxxxxxx, xxxxx xxxx

Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxx k xxxxxxx

Xxxx

x

x

x

x

x

x

x

x

x

„311

Xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx oxid

Trimethylbenzoyl xxxxxxxxxxxxxxxxx xxxxx

75980-60-8

278-355-8

Xxxxxxx umělých nehtů

5,0 %

Xxxxxxxxxxxxx xxxxxxx

Xxx xxx xxxxxxxxxxxxx xxxxxxx.

Xxxxxxxx xxxxx x xxxx.

Xxxxx xxxxxxx xxxxx k xxxxxxx.

312

2-Xxxxxxxxxx

Xxxxxxxx

98-01-1

202-627-7

0,001 %“

3)&xxxx;&xxxx;&xxxx;

Xxxxxxx X&xxxx;xx xxxx xxxxx:

x)

x&xxxx;xxxxx xx xxx 2 nahrazuje tímto:

„2.

 Veškeré xxxxxxx xxxxxxx obsahující xxxxx xxxxxxx v této xxxxxxx, x&xxxx;xxxxx xx xxxxxxxx formaldehyd, musí xxx xxxxxxxx xxxxxxxxxxx „xxxxxxxx xxxxxxxxxxx“, xxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxx xxxxxxxx 0,05 %.“;

b)

položky 5, 31, 40 x&xxxx;41 xx xxxxxxx;

x)

xxxxxxx 28 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx číslo

Identifikace látky

Podmínky

Znění xxxxxxxx xxxxxxx a xxxxxxxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx v xxxxxxx xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxx

Xxxxx XXX

Xxxxx XX

Xxxx výrobku, části xxxx

Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxx x xxxxxxx

Xxxx

x

x

x

x

x

x

x

x

x

„28

Xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx

Xxxxxxxxxxxxxxx biguanide

32289-58-0,

27083-27-8,

28757-47-3,

133029-32-0

608-723-9

608-042-7

0,1 %

Nepoužívat x aplikacích, xxx xxxxx vést k xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx při vdechování.“

(*1)  Směrnice Xxxxxxxxxx parlamentu x Xxxx 2005/36/XX ze xxx 7. xxxx 2005 o xxxxxxxx xxxxxxxxx kvalifikací (Xx. xxxx. X&xxxx;255, 30.9.2005, x.&xxxx;22).“